Clinical relevance of the distribution of the lesions in 500 consecutive breast cancer cases documented in large-format histologic sections

Cancer

Volumn 110, Issue 11, 2007, Pages 2551-2560

  Tot, Tibor ^a  

^a FALUN HOSPITAL   (Sweden)

Author keywords

Breast cancer; Diffuse growth; Distribution; Extent; Large section histology; Lymph node metastasis; Multifocal; Sick lobe theory; Unifocal

Indexed keywords

ARTICLE; BREAST CANCER; BREAST LESION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CANCER SIZE; CLINICAL ASSESSMENT; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TISSUE SECTION;

BREAST NEOPLASMS; CARCINOMA; CARCINOMA IN SITU; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MASTECTOMY; NEOPLASM INVASIVENESS; RETROSPECTIVE STUDIES;

EID: 36448990046     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23052     Document Type: Article

References (37)

1. Gallager HS, Martin JE. The study of mammary carcinoma by mammography and whole organ sectioning. Cancer. 1969;23:855-873.
2. Egan RI. Multicentric breast carcinomas: clinical - radiographic pathologic whole organ studies and 10-year survival. Cancer. 1982;49:1123-1130.
3. Holland R, Veling SH, Mravunac M, et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
4. Connolly JL, Harris JR, Schnitt SJ. Understanding the distribution of cancer within the breast is important for optimizing breast-conserving treatment [editorial]. Cancer. 1995;76:1-3.
5. Andea AA, Wallis T, Newman LA, et al. Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma. Cancer. 2002;94:1383-1390.
6. Andea AA, Bouwman D, Wallis T, et al. Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma. Cancer. 2004;100:20-27.
7. Coombs NJ, Boyages J. Multifocal and multicentric breast cancer: does each focus matter J Clin Oncol. 2005;23:7497-7502.
8. Pedersen L, Gunnarsdottir KA, Rasmussen BB, et al. The prognostic influence of multifocality in breast cancer patients. Breast. 2004;13:188-193.
9. Tresserra F, Rodriguez I, Garcia-Yuste M, et al. Tumor size and lymph node status in multifocal breast cancer. Breast J. 2007;13:68-71.
10. Tot T. The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis. Virchows Arch. 2003;443:718-724.
11. Faverly DRG, Hendricks JHCL, Holland R. Breast carcinoma of limited extent. Frequency, radiologic - pathologic characteristics, and surgical margin requirements. Cancer. 2001;91:647-659.
12. Holland R, Hendricks JH, Vebeek AL, et al. Extent, distribution, and mammographic/histological correlation of breast ductal carcinoma in situ. Lancet. 1990;335:519-522.
13. Tot T. DCIS, cytokeratins and the theory of the sick lobe. Virchows Arch. 2005;447:1-8.
14. Tot T, Tabar L. Radio-pathologic correlation of ductal carcinoma in situ of the breast using 2- and 3-dimensional large histologic sections. Semin Breast Dis. 2005;8:144-151.
15. Jackson PA, Merchant W, McCormick CJ, et al. A comparison of large block macrosectioning and conventional techniques in breast pathology. Virchows Arch. 1994;425:243-248.
16. Mechine-Neuville A, Chenard MP, Gairard B, et al. Large sections in routine breast pathology. A technique adapted to conservative surgery. Ann Pathol. 2000;20:275-209.
17. Fochsini MP, Tot T, Eusebi V. Large section (macrosection) histologic slides. In: Silverstein MJ, editor. Ductal Carcinoma in Situ of the Breast. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins; 2002:249-254.
18. Tot T, Tabar L, Dean PB. The pressing need for better mammographic - pathologic correlation of many variations in normal breast anatomy. Virchows Arch. 2000;437:338-344.
19. Biesemier KW, Alexander CM. Enhancement of mammographic-pathologic correlation utilizing large format histology for malignant breast diseases. Semin Breast Dis. 2005;8:152-162.
20. Tot T, Tabar L, Dean PB. Practical Breast Pathology. Stuttgart: Thieme; 2002:116-123.
21. Tabar L, Tot T, Dean PB. Breast Cancer, The Art and Science of Early Detection with Mammography. Stuttgart: Thieme; 2005:405-438.
22. Tavassoli FA, Devilee P, editors. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
23. Greene FL, Page DL, Fleming ID, et al., editors. AJCC Cancer Staging Manual. 6th ed. New York: Springer; 2002.
24. Chapgar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106:1462-1466.
25. Luttges J, Kalbfleisch H, Prinz P. Nipple involvement and multicentricity in breast cancer. A study of whole organ sections. J Cancer Res Clin Oncol. 1987;113:481-487.
26. Going JJ, Mohun TJ. Human breast duct anatomy, the 'sick lobe' hypothesis and intraductal approaches to breast cancer. Breast Cancer Res Treat. 2006;97:285-291.
27. Orbo A, Stalsberg H, Kunde D. Topographic criteria in the diagnosis of tumor emboli in intramammary lymphatic. Cancer. 1990;66:972-977.
28. Pinder SE, Ellis IO, Galea M, et al. Pathological prognostic factors in breast cancer. III. Vascular invasion: relationship with recurrence and survival in a large study with long-term follow-up. Histopathology. 1994;24:41-47.
29. Woo CS, Silberman H, Nakamura SK, et al. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg. 2002;184:337-340.
30. Hartveit F. Attenuated cells in breast stroma: the missing lymphatic system of the breast. Histopathology. 1990;16:533-543.
31. Fisher ER, Constantino J, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). The National Surgical Adjuvant Breast and Bowel Project Collaborating Investigators. Cancer. 1995;75:1310-1319.
32. Silverstein MJ, Cohlan BF, Gierson FD, et al. Duct carcinoma in situ: 227 cases without microinvasion. Eur J Cancer. 1992;28:630-634.
33. Faverly DRG, Burgers L, Bult P, et al. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol. 1994;11:193-198.
34. Andersen JA, Blichert-Toft M, Dyreborg U. In situ carcinomas of the breast. Types, growth pattern, diagnosis, and treatment. Eur J Surg Oncol. 1987;13:105-111.
35. Millis RR, Ryder K, Fentiman IS. Ductal in situ component and prognosis of invasive mammary carcinoma. Breast Cancer Res Treat. 2004;84:197-198.
36. Tabar L, Chen HT, Yen MFA, et al. Mammographic tumor features can predict long-term outcomes reliably in women with 1-14-mm invasive breast carcinoma. Cancer. 2004;101:1745-1759.
37. Tabar L, Tot T, Dean PB. Breast Cancer: Early Detection with Mammography. Casting Type Calcifications: Sign of a Subtype with Deceptive Features. Stuttgart: Thieme; 2007.